Yüklüyor......
The therapeutic potential of mTOR inhibitors in breast cancer
Rapamycin and modified rapamycins (rapalogs) have been used to prevent allograft rejection after organ transplant for over 15 years. The mechanistic target of rapamycin (mTOR) has been determined to be a key component of the mTORC1 complex which consists of the serine/threonine kinase TOR and at lea...
Kaydedildi:
| Yayımlandı: | Br J Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061784/ https://ncbi.nlm.nih.gov/pubmed/27059645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12958 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|